Difference between revisions of "Ketamine"
From WikiAnesthesia
Chris Rishel (talk | contribs) m |
Chris Rishel (talk | contribs) m (Added embedded dosage calculation) |
||
Line 6: | Line 6: | ||
| drug_class_color = sedative_hypnotic | | drug_class_color = sedative_hypnotic | ||
| uses = Induction and maintenance of anesthesia, sedation, analgesia | | uses = Induction and maintenance of anesthesia, sedation, analgesia | ||
| contraindications = | | contraindications = * <3 months old | ||
* <3 months old | |||
* Situations where elevated blood pressure or myocardial oxygen demand would be dangerous | * Situations where elevated blood pressure or myocardial oxygen demand would be dangerous | ||
* Schizophrenia | * Schizophrenia | ||
* Use controversial with elevated ICP or IOP | * Use controversial with elevated ICP or IOP | ||
| routes = IV, IM, IN, PO, PR | | routes = IV, IM, IN, PO, PR | ||
| dosage = | | dosage = | ||
| dosage_calculation = ketamine | |||
| mechanism = NMDA antagonism | | mechanism = NMDA antagonism | ||
| adverse_effects = Laryngospasm | | adverse_effects = Laryngospasm |
Revision as of 23:12, 29 March 2022
Ketamine
Trade names |
Ketalar |
---|---|
Clinical data | |
Drug class |
Sedative hypnotic |
Uses |
Induction and maintenance of anesthesia, sedation, analgesia |
Contraindications |
|
Routes of administration |
IV, IM, IN, PO, PR |
Dosage | |
Pharmacodynamics | |
Mechanism of action |
NMDA antagonism |
Adverse effects |
Laryngospasm Hypersalivation Emesis Emergence reaction |
Pharmacokinetics | |
Onset of action |
|
Duration of action |
|
Metabolism |
Liver (CYP3A4, CYP2B6) |
Elimination half-life |
2.5-3 hours |
Protein binding |
23-47% |
Physical and chemical data | |
Formula |
C13H16ClNO |
Molar mass |
237.73 g/mol |
Article quality | |
Editor rating | |
User likes | 0 |
Ketamine is a dissociative anesthetic used for the induction of anesthesia, procedural sedation, and as an analgesic adjunct.